Milestone Pharmaceuticals Inc (MIST) — Cash Flow Reinvestment Rate
Latest as of June 2021:
19.75x
Milestone Pharmaceuticals Inc (MIST) has a Cash Flow Reinvestment Rate of 19.75x as of June 2021, reinvesting $20.05 Million (capex $46.00K plus investments $20.00 Million) from operating cash flow of $1.01 Million. Check Milestone Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
19.75x
(Capex + Investments) / Operating CF
Total Reinvested
$20.05 Million
Capex + Investments
Operating Cash Flow
$1.01 Million
USD
Capital Expenditures
$46.00K
USD
Annual Cash Flow Reinvestment Rate for Milestone Pharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Milestone Pharmaceuticals Inc. For live market cap and broader valuation context, see Milestone Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow